Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan.

  title={Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan.},
  author={Devasenan Devendra and Bharat Gohel and Vassiliki Bravis and Elaine Y L Hui and Suliman Salih and Saeed Mehar and Mohamed Hassanein},
  journal={International journal of clinical practice},
  volume={63 10},
AIMS To compare hypoglycaemic events, glycated haemoglobin (HbA(1c)) and changes in bodyweight in metformin-treated Muslim patients with type 2 diabetes receiving adjunctive treatment with vildagliptin or gliclazide during Ramadan fasting. METHODS Data were collected from Muslim patients with type 2 diabetes attending primary care practices in North West London, whose HbA(1c) was > 8.5% despite treatment with metformin 2 g daily before Ramadan and who received gliclazide 160 mg twice daily (n… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 37 extracted citations

Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan

Diabetes, metabolic syndrome and obesity : targets and therapy • 2012
View 7 Excerpts
Highly Influenced

Diabetes and Ramadan: Practical guidelines.

Diabetes research and clinical practice • 2017
View 1 Excerpt


Publications referenced by this paper.
Showing 1-10 of 16 references

European implications of the READ (Ramadan focused Education and Awareness in Diabetes) programme [Abstract

V Bravis, E Hui, +3 authors D. Devendra
tes mellitus. Diabetes Obes Metab • 2009

Hypoglycaemia in Type 2 diabetes

Diabetic medicine : a journal of the British Diabetic Association • 2008

The islet enhancer vildagliptin: mechanisms of improved glucose metabolism.

International journal of clinical practice. Supplement • 2008

Similar Papers

Loading similar papers…